wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28253501-8E8C0437-3181-40E8-93F8-5D7EA646F6F0
Q28253501-8E8C0437-3181-40E8-93F8-5D7EA646F6F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28253501-8E8C0437-3181-40E8-93F8-5D7EA646F6F0
Antibodies to watch in 2015
P2860
Q28253501-8E8C0437-3181-40E8-93F8-5D7EA646F6F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28253501-8E8C0437-3181-40E8-93F8-5D7EA646F6F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
895c5fe39854b96471e84a1ab641902665754492
P2860
Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized Phase 3 trial